20 May 2015 Treatment Advocates Denounce Gilead’s Embargo against Thousands of Tunisians Sufferin… Advocacy, ARV, Daclatasvir, HCV, Health Financing, Hepatitis, Intellectual Proprety, News, North Africa, Sofosbuvir 72 Views The Tunisian Association of Fight against STDs and AIDS (ATL Tunis) and the International Treatment Preparedness Coalition in MENA Region (ITPC-MENA) denounce the refusal of Gilead Sciences to make their drug against the Hepatitis
